poisar

Stocks · News reference

UBS Maintains Buy on CRH, Lowers Price Target to $135

BenzingaBenzinga Newsdesk

UBS analyst Julian Radlinger maintains CRH (NYSE:CRH) with a Buy and lowers the price target from $147 to $135.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading